These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7406916)

  • 1. The metabolism of chlorambucil.
    McLean A; Newell D; Baker G; Connors T
    Biochem Pharmacol; 1980 Jul; 29(14):2039-47. PubMed ID: 7406916
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of thymidylate synthetase of Walker carcinoma by chlorambucil. A possible mechanism of action.
    Srinivasan SK; Gupta VS; Howarth RE
    Biochem Pharmacol; 1977 Jun; 26(11):1027-32. PubMed ID: 880254
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolism of chlorambucil.
    McLean A; Newell D; Baker G
    Biochem Pharmacol; 1976 Oct; 25(20):2331-5. PubMed ID: 985564
    [No Abstract]   [Full Text] [Related]  

  • 4. Alkylating agents.
    Connors TA
    Top Curr Chem; 1974; 52():141-71. PubMed ID: 4617337
    [No Abstract]   [Full Text] [Related]  

  • 5. Teratogenicity of chlorambucil in rat embryos in vitro.
    Mirkes PE; Greenaway JC
    Teratology; 1982 Oct; 26(2):135-43. PubMed ID: 7157190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
    Volm M; Mattern J; Wayss K
    Arch Gynakol; 1977 Nov; 223(4):249-57. PubMed ID: 579579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of chlorambucil in ovarian carcinoma using a new HPLC assay.
    Leff P; Bardsley WG
    Biochem Pharmacol; 1979 Apr; 28(8):1289-92. PubMed ID: 444295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mode of action of chlorambucil. Initial metabolic studies using carbon 14 isotope labeling. Rheumatological implications of their results].
    Sauvezie B; Rampon S; Bussière JL; Godenèche D; Chollet P; Plagne R
    Rev Rhum Mal Osteoartic; 1975 May; 42(5):337-44. PubMed ID: 1145086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal and nuclear metabolism of 3-methylcholanthrene.
    Tierney B; Bresnick E; Sims P; Grover PL
    Biochem Pharmacol; 1979 Sep; 28(17):2607-10. PubMed ID: 518671
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor effect of chlorbutinpenicillin.
    Navashin SM; Fomina IP; Terent'eva TG
    Fed Proc Transl Suppl; 1965; 24(4):732-4. PubMed ID: 5213778
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of deuterated analogues of chlorambucil by the rat.
    Farmer PB; Foster AB; Jarman M; Newell DR; Oddy MR; Kiburis JH
    Chem Biol Interact; 1979 Dec; 28(2-3):211-24. PubMed ID: 549741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Walker carcinosarcoma 256 in study of anticancer agents. I. Method for simultaneous assessment of therapeutic value and toxicity.
    Rosenoer VM; Mitchley BC; Roe FJ; Connors TA
    Cancer Res; 1966 Aug; 26(8 Pt 2):937-41. PubMed ID: 5212554
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic disposition of chlorambucil in rats.
    Mitoma C; Onodera T; Takegoshi T; Thomas DW
    Xenobiotica; 1977 Apr; 7(4):205-20. PubMed ID: 868079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and bioreductive potential of a mono N-oxide derivative of the alkylating agent chlorambucil.
    Kirkpatrick DL; Schroeder HL; Chandler KJ
    Anticancer Drugs; 1994 Aug; 5(4):467-72. PubMed ID: 7949253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different sensitivity of two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule binding.
    Donelli MG; Guaitani A; Torti L; Damia G; Corti F; Bianchi M; Tortoreto M; Pantarotto C; Bartosek I
    Oncology; 1986; 43(4):257-63. PubMed ID: 3725287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the oxidation of 5H-N-substituted dibenz[b,f]azepines. III. Oxidative metabolism by rat liver microsomes.
    Ohta T; Miyata N; Hirobe M
    Chem Pharm Bull (Tokyo); 1986 Jun; 34(6):2494-500. PubMed ID: 3769067
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of tamoxifen by rat liver microsomes: formation of the N-oxide, a new metabolite.
    Foster AB; Griggs LJ; Jarman M; van Maanen JM; Schulten HR
    Biochem Pharmacol; 1980 Jul; 29(13):1977-9. PubMed ID: 7397005
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased hydroxylation of steroid hormones by liver microsomes from rats bearing Walker carcinosarcoma 256.
    Kato R; Takahashi A
    Cancer Res; 1970 Sep; 30(9):2346-52. PubMed ID: 5475480
    [No Abstract]   [Full Text] [Related]  

  • 19. Time course of glutathione S-transferase elevation in Walker mammary carcinoma cells following chlorambucil exposure.
    Clapper ML; Kuzmich S; Seestaller LM; Tew KD
    Biochem Pharmacol; 1993 Feb; 45(3):683-90. PubMed ID: 7680202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.
    Sladek NE
    Cancer Res; 1973 Jun; 33(6):1150-8. PubMed ID: 4718666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.